Ecstasy is the second most widely abused illegal drug in Europe. Ecstasy is the colloquial
name for 3, 4-methylenedioxymethamphetamine (MDMA), but not all Ecstasy tablets contain …

3, 4-Methylenedioxymethamphetamine (MDMA) is a relatively novel drug of abuse and as
such little is currently known of its behavioural pharmacology. This review aims to examine …

New psychoactive substances pose a particular challenge to those formulating drugs policy
and related public health responses. This paper outlines some of the main issues arising …

In the UK, mephedrone and other so‐called 'legal high'derivatives have recently been
classified as Class B, Schedule I under the Misuse of Drugs Act 1971. Since then, alternative …

Aims To examine the variation in the content of ecstasy tablets seized in the north‐west of
England during 2001 and to compare it to the UK average from 1991 to 2001 …

A large number of cathinone derivatives have shown a wide range of bioactive properties,
attracting great interest from communities associated with pharmaceutical research. Some of …

Previous investigations of the subjective effects of MDMA (material sold as ecstasy) have
conducted interviews and surveys of various groups of ecstasy users within particular sub …

Self-reported use of γ-hydroxybutyrate (GHB) among clubbers has increased over the last
decade, and is often reported in the scientific literature in association with negative events …

Cross-sectional and longitudinal studies have reported equivocal findings regarding the
association between self-esteem, self-efficacy and adolescent alcohol use. Data were …

'Rat Park'is the name given to a series of studies undertaken in the late 1970s by Bruce K.
Alexander and colleagues. They found that rats housed in enriched environments …